SLS Earnings

Quarterly EPS
$-0.10
Q3 2024
$-0.09
Q4 2024
$-0.07
Q1 2025
$-0.07
Q2 2025
$-0.06
Q3 2025
$-0.05
Q4 2025
$-0.05
Q1 2026
$-0.05
Q2 2026
Latest RevenueN/A
Latest Net Income-9605000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.050-9605000+28.6%
Q1 2026-$0.050-8407000+28.6%
Q4 2025-$0.050-7658000+44.4%
Q3 2025-$0.060-6791000+40.0%
Q2 2025-$0.070-6601000+46.2%
Q1 2025-$0.070-5813000+66.7%
Q4 2024-$0.090-6737000+65.4%
Q3 2024-$0.100-7108000+69.7%
Q2 2024-$0.130-7470000
Q1 2024-$0.210-9566000
Q4 2023-$0.260-8136000
Q3 2023-$0.330-9267000
SELLAS Life Sciences (SLS) — Earnings